More recently, Tang et al. found increased levels of Aβ, increased immunoreactivity of BACE1, and decreased immunoreactivity of ADAM10 in platelets of AD, indicating that the amyloidogenic pathway of the APP metabolism is activated in platelets of AD patients, paralleling the intracerebral APP processing in AD [4]. This evidence concerns the gene ADAM10 and Alzheimer disease.